» Journals » Clin Breast Cancer

Clinical Breast Cancer

Clinical Breast Cancer is a peer-reviewed medical journal that focuses on the diagnosis, treatment, and management of breast cancer. It provides comprehensive and up-to-date research articles, reviews, and case studies, offering valuable insights into the latest advancements in breast cancer care. The journal serves as a valuable resource for healthcare professionals, researchers, and clinicians seeking to enhance their understanding and improve patient outcomes in the field of clinical breast cancer.

Details
Abbr. Clin Breast Cancer
Publisher Elsevier
Start 2000
End Continuing
Frequency Bimonthly, 2010-
p-ISSN 1526-8209
e-ISSN 1938-0666
Country United States
Language English
Specialty Oncology
Metrics
h-index / Ranks: 4372 80
SJR / Ranks: 4203 942
CiteScore / Ranks: 5214 4.90
JIF / Ranks: 3327 3.1
Recent Articles
1.
Vasconcellos J, Bonadio R, Mendes S, Orsi B, Leis L, Messias A, et al.
Clin Breast Cancer . 2025 Mar; PMID: 40082193
Background: The management of breast cancer (BC) in elderly patients remains a topic of debate among specialists, with concerns regarding potential undertreatment. This study aimed to evaluate the impact of...
2.
Fischer U
Clin Breast Cancer . 2025 Mar; PMID: 40082192
Purpose: Calculation of the size growth of different types of breast carcinoma based on follow-up data in breast MRI. Patients And Methods: Patients were included if they had been diagnosed...
3.
4.
Li C, Du C
Clin Breast Cancer . 2025 Mar; PMID: 40069060
No abstract available.
5.
Wu J, Yang J, Duan J
Clin Breast Cancer . 2025 Mar; PMID: 40058991
Breast cancer (BC) remains one of the leading causes of cancer-related mortality worldwide, necessitating continuous advancements in therapeutic strategies. While anesthetic agents are traditionally used for managing pain and sedation...
6.
Mack M, McGee M, Bennie B, Arenz A, Dietrich L
Clin Breast Cancer . 2025 Mar; PMID: 40057460
Background: The COVID-19 pandemic disrupted breast cancer care, potentially affecting diagnosis stage, time to treatment initiation, and treatment modalities. This study evaluated how pandemic-related restrictions affected these factors at a...
7.
Cabioglu N, Karanlik H, Ozmen V, Tukenmez M, Igci A, Aytin Y, et al.
Clin Breast Cancer . 2025 Mar; PMID: 40055044
Purpose: Randomized trials including ACOSOG Z0011 and SENOMAC mostly included patients with hormone receptor-positive breast cancer, but a limited number of patients with aggressive tumor biology. Therefore, we assessed the...
8.
Liu H, Xia H, Yin X, Qin A, Zhang W, Feng S, et al.
Clin Breast Cancer . 2025 Mar; PMID: 40044534
Objective: To establish and validate a 2-dimensional ultrasound (US) radiomics model for the noninvasive preoperative differentiation of various molecular subtypes of infiltrating breast cancer (IBC). Methods: A retrospective analysis of...
9.
Wang J, Wang X, He Y, Wang T, Li J, Fan Z, et al.
Clin Breast Cancer . 2025 Mar; PMID: 40038007
Purpose: We aimed to determine whether patients with cytologically proven node-positive disease who achieved axillary pathologic complete response (ypN0) after neoadjuvant chemotherapy (NAC) have similar survival outcomes to those with...
10.
Fleege N, Loeffler B, Boehnke K, Henry N
Clin Breast Cancer . 2025 Feb; PMID: 40021432
Introduction: Cannabidiol (CBD) is a phytocannabinoid found in the plant Cannabis sativa and is thought to have broad potential therapeutic value. Little is reported on CBD use in patients with...